Search Results 801-810 of 21547 for Inhibition

1. Spatz3 Adjustable Balloon System® (Spatz3) Post Approval Study - Mayo Clinic

   Patients who are unable or unwilling to take prescribed proton pump inhibitor medication for the duration of the device implant. ... inhibitors (SNRIs), monoamine ...

2. Science Saturday: Addressing the challenges of chimeric antigen receptor-T cell therapy - Mayo Clinic News Network

   Kenderian said they could begin testing the dual-targeted CAR-T cell therapy in clinical trials in patients within two years. "We need strong, inhibition- ...

3. Safety and Efficacy of ALLO-715 and ALLO-647 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL) - Mayo Clinic

   At least 3 prior lines of MM therapy, including a proteasome inhibitor, ... - Use of strong/moderate CYP3A4 inhibitors, and strong CYP3A4 inducers within 14 days

4. Effectiveness of Deep Brain Stimulation for Treating People with Treatment Resistant Obsessive-Compulsive Disorder - Mayo Clinic

   ... inhibitor;; augmentation of one of the selective serotonin transporter inhibitors with clomipramine, and a neuroleptic (each for at least 2 weeks); and ...

5. An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Soc, Versus SoC Alone, in Adult Male Patients With mHSPC - Mayo Clinic

   adjuvant/neo-adjuvant therapy. - Up to 45 days of CYP17 inhibitor or ARDT exposure for metastatic prostate cancer is ... No CYP17 inhibitor or ARDT exposure for ...

6. Student Profiles - Training and Education - Center for Clinical and Translational Science (CCaTS)

   ... Inhibitors for the Treatment of Major Depressive Disorder. Lozada, Maria E. A New Clinically Based Staging System for Intrahepatic ...

7. Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC (VIGOR) - Mayo Clinic

   ... inhibitor (nivolumab) treatment plus platinum doublet chemotherapy. Participation eligibility. Participant eligibility includes age, gender, type and stage ...

8. Drugs and Supplements that Start with C - Mayo Clinic

   C1. C1 esterase inhibitor recombinant (intravenous route) · C1 esterase inhibitor, human (intravenous route, subcutaneous route). Back to top. Ca. Cabazitaxel ...

9. Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas - Mayo Clinic

   Participation eligibility · moderate or strong inhibitors or inducers of major CYP isoenzymes, including grapefruit, grapefruit hybrids, pomelos, star fruit, and ...

10. Marijuana - Mayo Clinic

    Protease inhibitors. Using cannabis may make these medicines not work as well. Medicines to prevent seizures. Avoid using cannabis when taking medicines to ...